Show simple item record

dc.contributor.authorAdams, Latif
dc.contributor.authorAfiadenyo, Michael
dc.contributor.authorKwofie, Samuel
dc.contributor.authorWilson, Michael D.
dc.contributor.authorKusi, Kwadow Asamoah
dc.contributor.authorObiri-Yeboah, Dorcas
dc.contributor.authorMoane, Siobhan
dc.contributor.authorMcKeon-Bennett, Michelle
dc.date.accessioned2023-04-06T14:21:13Z
dc.date.available2023-04-06T14:21:13Z
dc.date.copyright2023
dc.date.issued2023-04-01
dc.identifier.citationAdams, L., Afiadenyo, M., Kwofie, S.K., Wilson, M.D., Kusi, K.A., Obiri-Yeboah, D., Moane, S., McKeon-Bennett, M. (2023). In silico screening of phytochemicals from Dissotis rotundifolia against Plasmodium falciparum Dihydrofolate Reductase. Phytomedicine Plus. 3: 100447. https://doi.org/10.1016/j.phyplu.2023.100447en_US
dc.identifier.issn2667-0313
dc.identifier.urihttps://research.thea.ie/handle/20.500.12065/4467
dc.description.abstractBackground: Malaria remains a major health concern in developing countries with high morbidity and mortality, especially in pregnant women and infants. A major obstacle to the treatment of malaria is a low effectiveness and an increase resistance of the parasite to antimalarial drugs. As a result, there is an ongoing demand for new and potent antimalarial drugs. Medicinal plants remain a potential source for the development of new antimalarial drugs. Amongst them is Dissotis rotundifolia is an ethnomedical important plant used in West Africa to treat malaria. Purpose: This study aimed at identifying new potential antifolates by virtually screening phytochemicals characterized from the whole plant methanolic extract of D. rotundifolia against Plasmodium falciparum Dihydrofolate Reductase (PfDHFR). Methods: LC-ESI-Q-TOF-MS analysis was employed to identify the phytochemicals present in the whole plant methanolic extract of D. rotundifolia. These phytochemicals were docked against the catalytic site of PfDHFR. The docking protocol was evaluated using the Area Under the Curve (AUC) of a Receiver Operating Characteristic (ROC) curve. The binding mechanisms and the drug-likeness of the phytochemicals were characterized. A 100 ns Molecular Dynamics (MD) simulation and Molecular Mechanics-Poisson Boltzmann Surface Area (MM-PBSA) calculations were utilized to analyze the stability, the energy decomposition per residue and the binding free energy of the potential leads. Results: Twenty nine phytochemicals were characterized and docked against PfDHFR. Dimethylmatairesinol, flavodic acid, sakuranetin, and sesartemin were identified as potential leads with binding affinities of -8.4, -8.9, -8.6, and -8.9 kcal/mol respectively, greater than a stringent threshold of -8.0 kcal/mol. The potential leads also interacted hydrophobically with critical residue Phe58. A novel critical residue, Leu46 was identified to be crucial in the catalytic activity of PfDHFR. The potential leads were also predicted to be anti-protozoal with a probability of active (Pa) value ranging from 0.319 to 0.537. Conclusion: This study elucidates the potential inhibition of PfDHFR by dimethylmatairesinol, flavodic acid, sakuranetin and sesartemin present in D. rotundifolia. These compounds are druglike, do not violate Lipinski’s rule of five, have a high binding affinity to PfDHFR, and interact with crucial residues involved in the catalytic activity PfDHFR. Dimethylmatairesinol, flavodic acid, sakuranetinen_US
dc.formatPDFen_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.ispartofPhytomedicine Plusen_US
dc.rightsAttribution-3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectMalariaen_US
dc.subjectAntifolateen_US
dc.subjectDissotis rotundifoliaen_US
dc.subjectPhytochemicalen_US
dc.subjectPlastmodium falciparum Dihydrofolate Reducatase (PfDHFR)en_US
dc.subjectMolecular dockingen_US
dc.subjectMolecular dynamics simulationen_US
dc.titleIn silico screening of phytochemicals from Dissotis rotundifolia against Plasmodium falciparum Dihydrofolate Reductase.en_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.contributor.affiliationTechnological University of the Shannon: Midlands Midwesten_US
dc.description.peerreviewyesen_US
dc.identifier.doi10.1016/j.phyplu.2023.100447en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-6291-177Xen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-9651-9162en_US
dc.identifier.orcidhttps://orcid.org/0000-0003-1079-1494en_US
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessen_US
dc.subject.departmentDepartment of Pharmaceutical Sciences and Biotechnologyen_US
dc.type.versioninfo:eu-repo/semantics/publishedVersionen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-3.0 United States
Except where otherwise noted, this item's license is described as Attribution-3.0 United States